Can I Take Vitamin B12 with Rapamycin (Sirolimus)?

What Is the Direct Interaction Between Vitamin B12 and Rapamycin?

There is no documented direct pharmacokinetic or pharmacodynamic interaction between vitamin B12 and rapamycin (sirolimus). Vitamin B12 is a water-soluble cofactor absorbed via intrinsic factor in the terminal ileum and transported by transcobalamin II. Rapamycin is metabolized primarily by cytochrome P450 3A4 (CYP3A4) and P-glycoprotein in the gut wall and liver. These two pathways do not overlap in any clinically meaningful way.

How Rapamycin Is Metabolized

Sirolimus undergoes extensive first-pass metabolism via CYP3A4 and is a substrate of P-glycoprotein (P-gp) efflux transport [1]. The FDA prescribing information for Rapamune lists strong CYP3A4 inhibitors (ketoconazole, voriconazole, diltiazem) and inducers (rifampin, St. John's Wort) as agents that materially change sirolimus blood trough levels [2]. Vitamin B12, whether as cyanocobalamin, methylcobalamin, or hydroxocobalamin, does not inhibit or induce CYP3A4 or P-gp.

How Vitamin B12 Is Absorbed

B12 absorption depends on gastric acid, intrinsic factor secreted by gastric parietal cells, and cubilin receptors in the terminal ileum [3]. None of these steps intersect with the mTOR signaling pathway that sirolimus blocks. One pharmacokinetic review published in the Journal of Clinical Pharmacology confirmed that water-soluble vitamins do not alter the bioavailability of calcineurin or mTOR inhibitors in solid-organ transplant recipients [4].

No dose-separation window is required. Oral B12 supplements, sublingual formulations, and intramuscular injections can all be taken without timing restrictions relative to your rapamycin dose.

Why the Metformin Connection Matters

The indirect concern is real. Rapamycin and metformin are frequently co-prescribed, both in organ-transplant immunosuppression regimens and in longevity medicine protocols. Metformin is a well-established cause of vitamin B12 depletion through a mechanism that involves calcium-dependent ileal membrane transport inhibition [5].

Metformin-Induced B12 Depletion: The Evidence

The landmark UK Prospective Diabetes Study and subsequent long-term analyses established that metformin reduces serum B12 concentrations. A meta-analysis by Niafar et al. (2015, N=4,829) found that metformin therapy was associated with a statistically significant decrease in serum B12 (mean difference: negative 57.96 pmol/L, P<0.001) compared with placebo or no treatment [6]. The Diabetes Prevention Program Outcomes Study (DPPOS) showed that 4 years of metformin at 1,700 mg/day produced a 19% prevalence of B12 deficiency versus 10% in the placebo group (P<0.001) [7].

What Deficiency Looks Like Clinically

Low B12 causes megaloblastic anemia, peripheral neuropathy, and subacute combined degeneration of the spinal cord. The neuropathy from B12 deficiency can mimic or worsen the peripheral neuropathy occasionally reported with sirolimus-based immunosuppression regimens [8]. Distinguishing drug toxicity from nutritional deficiency requires measuring serum B12 alongside methylmalonic acid (MMA) and homocysteine. Elevated MMA is the earliest sensitive marker of functional B12 deficiency, even when serum B12 is low-normal [9].

Does Rapamycin Itself Affect B12 Status?

MTOR inhibition affects cellular nutrient sensing and autophagy pathways. A 2021 study in Aging Cell found that rapamycin at clinically relevant concentrations (10 nM) altered one-carbon metabolism in mouse embryonic fibroblasts, a pathway in which B12 serves as a cofactor [10]. Whether this produces a meaningful change in B12 requirements in humans taking intermittent low-dose rapamycin (the common longevity protocol) has not been studied in a randomized trial. The signal is biological plausibility only.

Monitoring Recommendations for Combined Users

Annual measurement of serum B12 is the minimum standard. The American Diabetes Association (ADA) 2024 Standards of Care state: "Periodic measurement of vitamin B12 levels should be considered in metformin-treated patients, especially those with peripheral neuropathy or anemia" [11]. That guidance applies most directly to metformin, but the HealthRX medical team extends the same logic to rapamycin users taking concurrent metformin.

Suggested Lab Panel

For any patient on sirolimus who also takes metformin, an annual panel should include:

• Serum vitamin B12 (target above 300 pg/mL; some clinicians prefer above 400 pg/mL in older adults)
• Methylmalonic acid (MMA), serum or urine
• Homocysteine, plasma
• Complete blood count with differential (to detect macrocytic anemia)
• Sirolimus trough level (to confirm drug adherence and rule out toxicity as a cause of neurological symptoms)

A serum B12 between 200 and 300 pg/mL is the gray zone. MMA above 0.27 micromol/L in this range confirms functional deficiency and warrants supplementation [9].

What to Do If B12 Is Low

Oral cyanocobalamin 1,000 mcg daily corrects deficiency in most patients who have intact gastric function [3]. For patients with gastric atrophy, prior gastric bypass, or confirmed intrinsic-factor deficiency, intramuscular hydroxocobalamin 1,000 mcg monthly is the preferred repletion route. Neither form interacts with sirolimus pharmacokinetics.

Rapamycin Dose Forms and Relevant Drug Interactions to Know

Sirolimus is available as Rapamune oral solution (1 mg/mL) and tablets (0.5 mg, 1 mg, 2 mg) [2]. Off-label longevity use typically involves weekly doses of 1 to 6 mg, although no standardized dose has been established by a completed phase III trial in healthy aging adults. The PEARL trial (NCT04488601) is evaluating low-dose intermittent rapamycin in older adults; results are pending.

Interactions That Actually Affect Sirolimus Levels

The following agents do interact with sirolimus and are worth knowing in context:

• Strong CYP3A4 inhibitors (ketoconazole, itraconazole, voriconazole, clarithromycin, erythromycin): increase sirolimus trough levels 5- to 15-fold [2]
• Strong CYP3A4 inducers (rifampin, rifabutin, St. John's Wort): decrease sirolimus exposure by up to 82% [2]
• Grapefruit juice: inhibits intestinal CYP3A4 and can unpredictably increase sirolimus blood levels [2]
• Cyclosporine (Sandimmune, Neoral): when co-administered, increases sirolimus Cmax roughly 4-fold; spacing doses 4 hours apart is required per labeling [2]

Vitamin B12 appears on none of these interaction lists. The Natural Medicines database (Therapeutic Research Center) rates the interaction between B12 and sirolimus as "no known interaction" [12].

Fat-Soluble vs. Water-Soluble Supplement Distinctions

Fat-soluble supplements (vitamins A, D, E, K) taken simultaneously with sirolimus tablets could theoretically alter GI absorption if they significantly change lipid micelle formation. Vitamin B12 is water-soluble and poses no such concern. High-dose vitamin E (>400 IU) and vitamin K (relevant for anticoagulation management post-transplant) deserve more caution than B12, though their interactions with sirolimus are also pharmacodynamic rather than pharmacokinetic.

Special Populations

Solid-Organ Transplant Recipients

Post-transplant patients are often on calcineurin inhibitors alongside sirolimus, plus antihypertensives, antifungals, and sometimes metformin for post-transplant diabetes mellitus (PTDM). PTDM develops in 10 to 40% of kidney transplant recipients, and metformin is increasingly used in this population per 2022 KDIGO guidelines [13]. These patients carry the highest combined risk for B12 depletion: metformin use, possible gastric acid suppression from proton pump inhibitors (also prescribed post-transplant), and physiologic stress.

Older Adults on Longevity Protocols

Adults over 60 already have reduced gastric acid and intrinsic-factor output, making B12 absorption 20 to 30% less efficient than in younger adults [3]. Adding low-dose weekly rapamycin and, commonly, metformin creates additive depletion risk. The Linus Pauling Institute recommends crystalline B12 supplementation for all adults over 50 regardless of other medications, citing absorption data from the Framingham Heart Study cohort [14].

Patients with Prior Bariatric Surgery

Roux-en-Y gastric bypass and sleeve gastrectomy both reduce intrinsic-factor availability. B12 deficiency rates reach 30 to 40% at 5 years post-bypass without supplementation [15]. If rapamycin and metformin are added to this picture, intramuscular B12 becomes the only reliable repletion route.

Practical Dosing and Timing Guidance

The HealthRX medical team uses the following stepwise framework for patients starting or already taking rapamycin who ask about vitamin B12:

Step 1. Baseline labs before or at the time rapamycin is initiated. Order serum B12, MMA, homocysteine, and CBC. Document baseline sirolimus trough 5 to 7 days after the first dose.

Step 2. Identify co-prescriptions that deplete B12. Metformin is the main culprit. Proton pump inhibitors (omeprazole, pantoprazole) taken for more than 12 months also reduce B12 absorption by impairing gastric acid-dependent release of protein-bound B12 from food [16].

Step 3. Choose a supplement form. For patients with no absorption concerns, oral cyanocobalamin 500 to 1,000 mcg daily is cost-effective and adequate. Methylcobalamin is biologically active without hepatic conversion and may be preferred by patients with MTHFR variants, though evidence of superiority for peripheral neuropathy prevention is limited [17].

Step 4. Timing. Take B12 at any time. Morning dosing with breakfast is convenient and has no interaction with rapamycin regardless of whether rapamycin is taken on a fed or fasted stomach.

Step 5. Retest at 12 months. Confirm serum B12 is above 300 pg/mL and MMA has normalized.

What the Research Gap Means for You

No randomized controlled trial has specifically examined vitamin B12 status in humans taking rapamycin as a longevity agent. The off-label use context is new, and long-term cohort data are absent. The ITP (Interventions Testing Program) rapamycin mouse studies, which showed life-span extension of 9 to 14% in genetically heterogeneous mice [18], did not measure B12 status. Translating mouse ITP data to human micronutrient needs is speculative.

Given the absence of direct evidence of harm, a conservative approach is sensible: screen for deficiency, correct it if present, and recheck annually. A serum B12 below 200 pg/mL in a symptomatic patient (fatigue, tingling, gait instability) warrants prompt repletion regardless of other drug exposures.